[Biochemical basis of the treatment of leukemia with cytosine-arabinoside].
D003561:Cytarabine / Q000494:pharmacology / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D007962:Leukocytes / Q000187:drug effects / Q000201:enzymology; D011239:Prednisolone / Q000627:therapeutic use; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013937:Thymidine Kinase / Q000378:metabolism
D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D003561:Cytarabine; D011239:Prednisolone; D013937:Thymidine Kinase
Biochemische Grundlagen der Leukämiebehandlung mit Cytosinarabinosid.